首页>Clinical advances in hematology & oncology: H&O>Complete response to brentuximab vedotin in a transplant-na?ve patient with relapsed cd30-positive nodular lymphocyte-predominant hodgkin lymphoma
Complete response to brentuximab vedotin in a transplant-na?ve patient with relapsed cd30-positive nodular lymphocyte-predominant hodgkin lymphoma
作者单位：Department of Hematology-Oncology, Georgetown University Medical Center, Washington, DC, United[1]Department of Pathology, Georgetown University Medical Center, Washington, DC, United States[2]Department of Radiology, MedStar Georgetown University Hospital, Washington, DC, United States[3]Medical Oncology Branch, National Institutes of Health, Bethesda, MD, United States[4]
换一批
换一批
